Add Yahoo as a preferred source to see more of our stories on Google. A new study shows that a dual-action inhaler cuts asthma attacks in children almost in half. (CREDIT: Imperial College London) For ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...

In patients with mild asthma, as-needed use of an inhaled glucocorticoid plus a fast-acting β 2-agonist may be an alternative to conventional treatment strategies. We conducted a 52-week, double-blind ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...

The first generic version of Symbicort -- a metered-dose inhaler that combines the corticosteroid budesonide with the long-acting bronchodilator formoterol -- has been approved for asthma and chronic ...

This was a prospective, open-label, multicentre, randomised, parallel-group comparison of formoterol monotherapy with a fixed combination of ipratroprium bromide and fenoterol. Patients were assessed ...

Symbicort is an inhaler used for long-term control of asthma and COPD, but it is not a rescue inhaler. Before using Symbicort, tell your healthcare provider if you have health conditions like adrenal ...

San Diego, Calif., May 19, 2009 – Data from two presentations highlighting the use of Perforomist® (formoterol fumarate) Inhalation Solution in moderate to severe chronic obstructive pulmonary disease ...

This study demonstrates equivalent efficacy of the long-acting ß 2-adrenoceptor agonist formoterol and the combination of the anticholinergic drug ipratroprium bromide and the short-acting ß ...